Home › Kidney Cancer › Colorado › Centennial
Kidney Cancer clinical trials in Centennial, CO
3 studies for Kidney Cancer are looking for participants at sites in and around Centennial (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
RecruitingPhase 1
- Rocky Mountain Cancer Centers, LLP, Lone Tree · 2 mi away
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RecruitingPhase 1/2
- Rocky Mountain Cancer Centers,LLP, Lone Tree · 2 mi away
- UC Health Lone Tree Medical Center, Lone Tree · 2 mi away
Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
RecruitingPhase 2
- Lone Tree Medical Center, Lone Tree · 2 mi away
About Kidney Cancer
Kidney cancer symptoms are hard to detect at first but they do exist. Read more about the top 5 symptoms and the treatment options available
More about Kidney Cancer on MedlinePlus
Kidney Cancer trials in other cities
- New York City, NY15 studies
- Boston, MA12 studies
- Nashville, TN12 studies
- Houston, TX10 studies
- Washington, DC9 studies
- San Diego, CA9 studies
- St. Louis, MO9 studies
- Dallas, TX9 studies
- Seattle, WA8 studies
- Edison, NJ8 studies
- Jacksonville, FL7 studies
- Los Angeles, CA7 studies
Other studies in Centennial
- Non-Small Cell Lung Cancer15 studies
- Colorectal Cancer9 studies
- Breast Cancer9 studies
- Lung Cancer8 studies
- Prostate Cancer7 studies
- Bladder Cancer7 studies
- Kidney Cancer (Renal Cell Carcinoma)6 studies
- Metastatic Cancer5 studies
- Stomach Cancer5 studies
- Colon Cancer4 studies
- Esophageal Cancer4 studies
- Pancreatic Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.